Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ITP Immune-Mediated Thrombocytopenia”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07278908
What this trial is testing

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 248
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Ended earlyNCT05502783
What this trial is testing

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI) 1
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableNot Yet RecruitingNCT06790888
What this trial is testing

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Who this might be right for
ITP - Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 78
Not applicableLooking for participantsNCT06919341
What this trial is testing

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Who this might be right for
ITP - Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía 1,000
Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25
Not applicableStudy completedNCT05613296
What this trial is testing

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Who this might be right for
ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
Gruppo Italiano Malattie EMatologiche dell'Adulto 95
Not applicableUnknownNCT06093529
What this trial is testing

Immune Markers in Pediatric ITP on Second Line Therapy

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 42
Large-scale testing (Phase 3)Looking for participantsNCT07194850
What this trial is testing

Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITP - Immune ThrombocytopeniaITP+4 more
argenx 24
Early research (Phase 1)WithdrawnNCT06291415
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaBlood Platelet DisorderHematologic Diseases+14 more
Hutchmed
Testing effectiveness (Phase 2)Looking for participantsNCT06352281
What this trial is testing

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
ITP - Immune Thrombocytopenia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Not applicableNot Yet RecruitingNCT07014904
What this trial is testing

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 80
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Not applicableLooking for participantsNCT07093606
What this trial is testing

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 100
Not applicableNot Yet RecruitingNCT06137105
What this trial is testing

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459114
What this trial is testing

TGD001 Treatment in Thrombotic Microangiopathies

Who this might be right for
Thrombotic MicroangiopathiesITP Immune-Mediated Thrombocytopenia
TargED Biopharmaceuticals B.V. 70
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)UnknownNCT05943691
What this trial is testing

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Who this might be right for
ITP - Immune Thrombocytopenia
Shandong University 100
Not applicableUnknownNCT06273956
What this trial is testing

Explore the Relationship Between Platelet Count and Bleeding Score in ITP

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 100
Next Page